Condition
Focal Segmental Glomerulosclerosis (FSGS) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Focal Segmental Glomerulosclerosis (FSGS) clinical trials that are recruiting, at sites in 6 countries (most in China (3), Germany (1), Italy (1)). By phase: Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 6Countries
Newest Focal Segmental Glomerulosclerosis (FSGS) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Everest001: a medicine for certain kidney diseases to see if it helps adults | Phase 2 | Beijing, Beijing Municipality and 1 other locations | Recruiting | May 29, 2026 |
| Autoimmune podocytopathy and anti-nephrin antibodies | — | Rochester, Minnesota and 13 other locations | Recruiting | Apr 8, 2026 |
| BAT4406F injection for people with Minimal Change Disease or Focal Segmental Glomerulosclerosis | Phase 2/3 | Beijing, Beijing Municipality | Recruiting | Mar 30, 2026 |
| Using Raman Spectroscopy to Diagnose Kidney Diseases | — | Jinan, Shandong | Recruiting | Jan 7, 2025 |
All recruiting trials (4)
-
Everest001: a medicine for certain kidney diseases to see if it helps adults
This study tests EVER001 in adults with FSGS, MCD, or IgA nephropathy to see if it can help reduce protein in the urine and improve kidney function.
-
Autoimmune podocytopathy and anti-nephrin antibodies
This study tests whether children and adults with nephrotic syndrome have anti-nephrin autoantibodies and whether those antibodies relate to relapses and treatment response.
-
BAT4406F injection for people with Minimal Change Disease or Focal Segmental Glomerulosclerosis
BAT4406F injections will be tested to see if they help people with Minimal Change Disease or Focal Segmental Glomerulosclerosis who recently reached remission after corticosteroid treatment.
-
Using Raman Spectroscopy to Diagnose Kidney Diseases
This study is testing a new way to diagnose kidney diseases by analyzing urine and blood samples from patients with specific kidney conditions to see if it can help identify the diseases more accurately.
Related topics
Quick answers
How many Focal Segmental Glomerulosclerosis (FSGS) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (3 trials), Germany (1 trial), Italy (1 trial), Mexico (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.